Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (71)

Name Institution Why
Mary-Ellen Taplin, M.D.Dana-Farber Cancer Institute Why?
Philip Kantoff, M.D.Brigham and Women's Hospital Why?
William Robert Berry, M.D.Harvard T.H. Chan School of Public Health Why?
Matthew Raymond Smith, M.D., Ph.D.Massachusetts General Hospital Why?
Christopher J Sweeney, M.B.,B.S.Dana-Farber Cancer Institute Why?
Meredith M Regan, Sc.D.Dana-Farber Cancer Institute Why?
Glenn J. Bubley, M.D.Beth Israel Deaconess Medical Center Why?
Paul George Mathew, M.D.Brigham and Women's Hospital Why?
Anthony V. D'Amico, M.D., Ph.D.Brigham and Women's Hospital Why?
Joseph O Jacobson, M.D.Dana-Farber Cancer Institute Why?
Guru Sonpavde, M.B.,B.S.Dana-Farber Cancer Institute Why?
Adam Kibel, M.D.Brigham and Women's Hospital Why?
Eirini Pectasides, M.D.Dana-Farber Cancer Institute Why?
William Upjohn Shipley, M.D.Massachusetts General Hospital Why?
Joseph Paul Newhouse, Ph.D.Harvard Medical School Why?
Per Page    Page  of 5last Nextnext
Search Criteria
  • Estramustine
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.